Clinical Trials
3 trialsNCT07589361 2026-05-15
VBS-CSI-PT-PED
Ruijin Hospital
Not yet recruiting
NCT03158064 2026-01-28
Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT06418789 2025-08-03
GERMAN
N.N. Petrov National Medical Research Center of Oncology
Phase 2 Recruiting